Edition:
United Kingdom

OptiNose Inc (OPTN.OQ)

OPTN.OQ on NASDAQ Stock Exchange Global Select Market

16.21USD
16 Feb 2018
Change (% chg)

$-0.21 (-1.28%)
Prev Close
$16.42
Open
$16.28
Day's High
$16.51
Day's Low
$16.05
Volume
7,786
Avg. Vol
--
52-wk High
$21.38
52-wk Low
$15.01

Chart for

About

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Optinose Announces $100 Mln Debt Financing From Athyrium Capital Management

* OPTINOSE ANNOUNCES $100 MILLION DEBT FINANCING FROM ATHYRIUM CAPITAL MANAGEMENT Source text for Eikon: Further company coverage:

02 Jan 2018

BRIEF-OptiNose Inc Qtrly Net Loss ‍$4.23 Per Share​

* OPTINOSE INC - QTRLY NET LOSS ‍$4.23 PER SHARE​ Source text for Eikon: (http://bit.ly/2BiwpZA) Further company coverage:

27 Nov 2017

BRIEF-Optinose announces closing of initial public offering

* Optinose announces closing of initial public offering and full exercise of underwriters’ option to purchase additional shares of common stock Source text for Eikon: Further company coverage:

17 Oct 2017

Earnings vs. Estimates